Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
|
|
BIOMERICA INC (BMRA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
10-Q
| Quarterly Report for the period ended August 31, 2023 |
| 10/02/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/27/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 08/25/2023 |
10-K
| Annual Report for the period ended May 31, 2023 |
| 07/26/2023 |
8-K
| Quarterly results |
| 07/03/2023 |
5
| BARBIERI ALLEN (Vice Chairman) has filed a Form 5 on BIOMERICA INC |
| 04/25/2023 |
8-K
| Quarterly results |
| 04/14/2023 |
10-Q
| Quarterly Report for the period ended February 28, 2023 |
| 03/07/2023 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits Inte...|
Docs:
|
"BIOMERICA, INC. UNDERWRITING AGREEMENT",
"Letter re: Shares of Common Stock of Biomerica, Inc.",
"Biomerica Announces Proposed Underwritten Public Offering of Common Stock",
"Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock",
"Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock IRVINE, Calif., March 07, 2023-Biomerica, Inc. , a global provider of advanced medical products, announced today the closing of its previously announced underwritten public offering of an aggregate of 3,333,333 shares of its common stock, par value $0.08 per share, at a price to the public of $2.40 per sharefor total gross proceeds of $8 million, before deducting underwriting discounts and commissions and other offering-related expenses payable by Biomerica. All of the shares of common stock sold in the offering were offered by Biomerica. Craig-Hallum Capital Group LLC acted as sole managing underwriter in connection with the offering. Biomerica intends to use the net proceeds of the offering for general..." |
|
| 03/02/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 03/02/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 03/02/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/14/2023 |
SC 13G/A
| Granahan Investment Management, LLC reports a 8.4% stake in BIOMERICA, INC. |
| 02/07/2023 |
8-K
| Investor presentation |
| 01/13/2023 |
10-Q
| Quarterly Report for the period ended November 30, 2022 |
| 12/29/2022 |
8-K/A
| Quarterly results |
| 12/16/2022 |
8-K
| Quarterly results |
| 12/16/2022 |
8-K
| Quarterly results |
| 12/09/2022 |
8-K
| Quarterly results |
| 12/09/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
8-K
| Quarterly results |
| 10/13/2022 |
10-Q
| Quarterly Report for the period ended August 31, 2022 |
| 09/27/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 08/29/2022 |
10-K
| Annual Report for the period ended May 31, 2022 |
| 06/24/2022 |
5
| BARBIERI ALLEN (Vice Chairman) has filed a Form 5 on BIOMERICA INC |
| 04/19/2022 |
8-K
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits Interactive Data |
| 04/14/2022 |
10-Q
| Quarterly Report for the period ended February 28, 2022 |
| 02/14/2022 |
SC 13G
| Granahan Investment Management, LLC reports a 8.8% stake in BIOMERICA, INC. |
| 02/10/2022 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
| 02/04/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2022 |
SC 13G/A
| Wellington Trust Company, National Association Multiple Common Trust Funds Trust, Micro Cap Equity Portfolio reports a 0% stake in BIOMERICA, INC. |
| 02/04/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/12/2022 |
10-Q
| Quarterly Report for the period ended November 30, 2021 |
| 12/16/2021 |
8-K
| Quarterly results |
|
|
|